Clinical Trials Logo
  1. Home
  2. Chronic Pain
  3. NCT01835704
  4. Details
NCT01835704 Clinical Trial

Health-economic Evaulation of Interventional Pain Mangement

Chronic Pain Clinical Trial

Official title:
Health-economic Evaluation of Interventional Pain Management Among Patients With Chronic Pain

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01835704
Other study ID # SE-Dnr-2012-446-31M-2
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2008
Est. completion date February 3, 2019

Study information
Verified date February 2019
Source Eques Indolor AB
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To establish the cost per QALY (Quality Adjusted life Years) gained all patients that are referred to a specialized interventional pain clinic are assessed by Euroqol EQ-5D to measure the health-related quality of life at the first visit and then during the following year. Quality of life is calculated from EQ-5D by using hte TTO-validated UK-value set. With this and calculations of the cost we will be able to calculate the cost per QALY-gained which makes it possible to compare interventional pain managment to other treatments for pain patients.

Recruitment information / eligibility
Status Completed
Enrollment 1540
Est. completion date February 3, 2019
Est. primary completion date February 3, 2019
Accepts healthy volunteers No
Gender All
Age group 15 Years to 99 Years
Eligibility Inclusion Criteria:

- All patients

Exclusion Criteria:

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Radio-frequency dennervation of facet joint

• Diagnostic nerve-blocks performed under direct x-ray vision

Locations
Country Name City State
Sweden Smärtkliniken i Umeå Umeå

Sponsors (1)
Lead Sponsor Collaborator
Eques Indolor AB

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Quality Adjusted Life gained QALY is calculated from the EQ-5D value using the TTO-validated UK value set accoring to ordinary health-economic evaluations. 1 year
Secondary Cost per QALY gained The cost per QALY gained is calculated according to normal health-economic evaluation models. 1 year
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain